Bemiltenase alfa

N/A

Report date: 2026/04/20 20:01:59

Base Information

Drug NameBemiltenase alfa
Drug Alias NameSTSP-0601
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsBlood Loss, SurgicalHemorrhageHemorrhagic Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu BioJeTay Biotechnology Co LtdMediLink Therapeutics Co LtdStaidson(Beijing) Biopharmaceuticals Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHemorrhageHemophilia BHemophilia A
Inactive IndicationsBlood Loss, SurgicalHemorrhagic Disorders

Other Information

ATC CodeN/A
Related LinksN/A